Hypoglycemia and hyperglycemia associated with gatifloxacin use in elderly patients

Journal of the American Board of Family Practice

Volumn 16, Issue 5, 2003, Pages 455-457

  Biggs, Wendy S ^a  

^a MidMichigan Medical Center Midland   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGITALIS; GATIFLOXACIN; GLIBENCLAMIDE; GLIPIZIDE; GLUCOSE; INSULIN; METFORMIN; PENICILLIN G; PREDNISONE; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DIABETES MELLITUS; DRUG INTOXICATION; DRUG WITHDRAWAL; FEMALE; FEVER; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; LABORATORY TEST; LOW DRUG DOSE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PENICILLIN ALLERGY; PNEUMONIA; URINARY TRACT INFECTION; CHEMICALLY INDUCED DISORDER;

AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; FEMALE; FLUOROQUINOLONES; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; MALE;

EID: 2342452678     PISSN: 08938652     EISSN: 15448770     Source Type: Journal    
DOI: 10.3122/jabfm.16.5.455     Document Type: Article

References (9)

1. Oliphant CM, Green GM. Quinolones. A comprehensive review. Am Fam Physician 2002;65:455-64.
2. Anonymous. Gatifloxacin and moxifloxacin: two new fluoroquinolones. Med Lett Drugs Ther 2000;42:15-7.
3. Grasela D, Lacreta F, Kollia G, Randall D, Stoltz R, Berger S. Lack of effect of multiple-dose gatifloxacin (GAT) on oral glucose tolerance (OGTT), glucose and insulin homeostasis, and glyburide pharmacokinetics (PK) in patients with type II non-insulin dependent diabetes mellitus (NIDDM) [abstract]. In: Proceedings and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1999 Sep 26-29; San Francisco, California. Washington, DC: American Society for Microbiology, 1999:11.
4. Package insert. Tequin (gatifloxacin). Princeton, NJ: Bristol-Meyers Squibb Company, 2002 April.
5. Package insert. Tequin (gatifloxacin). Princeton, NJ: Bristol-Meyers Squibb Company, 2000 February.
6. Gajjar DA, LaCreta FP, Kollia GD. Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise. Pharmacotherapy 2000;20:76S-86S.
7. Gajjar DA, LaCreta FP, Uderman HD, et al. A dose-escalation study for the safety, tolerability, and pharmacokinetics of intravenous gatifloxacin in healthy adult men. Pharmacotherapy 2000;20:49S-58S).
8. Grasela DM. Clinical pharmacology of gatifloxacin, a new fluoroquinolone. Clin Infect Dis 2000;31 Suppl 2:S51-8.
9. Rajagopalan S, Yoshikawa TT. Antimicrobial therapy in the elderly. Med Clin North Am 2001;85:133-47.